相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Phase I Trial of Pazopanib in Patients with Advanced Cancer
Herbert I. Hurwitz et al.
CLINICAL CANCER RESEARCH (2009)
Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non-Small-Cell Lung Cancer
Gregory J. Riely et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation
Michael D. Oberst et al.
BMC CANCER (2008)
Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics
Patrizia Sini et al.
CANCER RESEARCH (2008)
HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
Michael F. Press et al.
CLINICAL CANCER RESEARCH (2008)
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells
Roberto Bianco et al.
CLINICAL CANCER RESEARCH (2008)
Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
Guru Sonpavde et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer
Anna Maria Storniolo et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide (pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Paolo M. Comoglio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The p53 family and programmed cell death
E. C. Pietsch et al.
ONCOGENE (2008)
Drug Insight: gastrointestinal stromal tumors (GIST) - the solid tumor model for cancer-specific treatment
Stefan Sleijfer et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Drug insight: intracellular inhibitors of HER2 - clinical development of lapatinib in breast cancer
David A. Cameron et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
Ilio Vitale et al.
PLOS ONE (2007)
Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non-small cell lung cancer
Tom Donnem et al.
CLINICAL CANCER RESEARCH (2007)
Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response
Joung Hyuck Joo et al.
CANCER RESEARCH (2007)
Controlling cell growth and survival through regulated nutrient transporter expression
Aimee L. Edinger
BIOCHEMICAL JOURNAL (2007)
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
Thibault de la Motte Rouge et al.
CANCER RESEARCH (2007)
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
Rakesh Kumar et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts
A. Bozec et al.
BRITISH JOURNAL OF CANCER (2007)
Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1
Tae-Hee Lee et al.
PLOS MEDICINE (2007)
Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles
Priti S. Hegde et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts
Neelu Puri et al.
CANCER RESEARCH (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma
Klaus Podar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels
Barbara A. Helfrich et al.
CLINICAL CANCER RESEARCH (2006)
A novel HSF1-mediated death pathway that is suppressed by heat shock proteins
Naoki Hayashida et al.
EMBO JOURNAL (2006)
Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage
Jaouhar Mourali et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Targeting the c-Met signaling pathway in cancer
Benedetta Peruzzi et al.
CLINICAL CANCER RESEARCH (2006)
Apoptosis regulation in tetraploid cancer cells
Maria Castedo et al.
EMBO JOURNAL (2006)
Differential gene expression detection and sample classification using penalized linear regression models
BL Wu
BIOINFORMATICS (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells
F Fan et al.
ONCOGENE (2005)
Differential control of G0 programme in chronic lymphocytic leukaemia:: a novel prognostic factor
AV Danilov et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Kinomics: methods for deciphering the kinome
SA Johnson et al.
NATURE METHODS (2005)
Protein kinase inhibitors: Insights into drug design from structure
MEM Noble et al.
SCIENCE (2004)
Identification of the apoptosis activation cascade induced in mammary carcinomas by energy restriction
HJ Thompson et al.
CANCER RESEARCH (2004)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
limmaGUI: A graphical user interface for linear modeling of microarray data
JM Wettenhall et al.
BIOINFORMATICS (2004)
Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets
CJ Barnes et al.
CANCER AND METASTASIS REVIEWS (2003)
Atypical Rho GTPases have roles in mitochondrial homeostasis and apoptosis
Å Fransson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells
V Golubovskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1
J Hulit et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Quantitation of mitochondrial alterations associated with apoptosis
M Castedo et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement
D Nadano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
